MétaCan
Menu
Back to cohort
Record W2039208380 · doi:10.1158/1538-7445.am2013-1336

Abstract 1336: A population-based study of Transforming Growth Factor-Beta1 (TGFB1) polymorphisms and risk of breast cancer.

2013· article· en· W2039208380 on OpenAlexaffabout
Mary A. Bewick, Michael Conlon

Bibliographic record

VenueCancer Research · 2013
Typearticle
Languageen
FieldBiochemistry, Genetics and Molecular Biology
TopicTGF-β signaling in diseases
Canadian institutionsNortheast Cancer Centre
Fundersnot available
KeywordsSingle-nucleotide polymorphismBreast cancerOdds ratioGenotypingGenotypeMedicineHaplotypeSNPOncologyCase-control studyInternal medicineSNP genotypingRisk factorConfidence intervalCancerPopulationBiologyGeneticsGene

Abstract

fetched live from OpenAlex

Abstract Transforming growth factor-beta1 (TGFB1) is a multifunctional cytokine that may play an important role in the development and progression of cancer. The results of a number of association studies of TGFB1 polymorphisms and breast cancer risk are inconclusive. This study examined 4 single nucleotide polymorphisms (SNPs) in TGFB1 and risk of breast cancer using data previously collected from a population based case-control study (n=307 cases and 664 controls) of Caucasian women conducted in Northeastern Ontario, Canada. The SNPs (rs8179181, rs8110090, rs1800470 (L10P), rs1800469 (-509C/T)) were selected as either tag SNPs or had been identified as potentially functional in other studies, and were analysed using Taqman genotyping assays. Two of the SNPs were at the 5’ end (rs1800469 (-509C/T), rs1800470) and were in high LD (D’ 0.98); the remaining SNPs (rs8179181, rs8110090) were at the 3’ end and were also in high LD (D’ 0.99). In single-SNP analyses, the variant homozygous genotypes in rs1800470 (CC) and rs8179181 (AA) were significantly protective in the codominant model with Odds Ratios (OR) and 95% Confidence Intervals (95% CIs) of 0.63 (0.40-0.99) and 0.45 (0.21-0.96), while the AG genotype of rs8110090 was significantly associated with increased breast cancer risk with an OR of 1.78 (95% CI 1.14-2.77). Of the seven estimated haplotypes, 3 were significantly protective for breast cancer; when compared to the referent haplotype (see Table). In conclusion, our results suggest that SNPs at both the 3’ and 5’ end of TGFB1 may be associated with risk of breast cancer, and future studies examining additional polymorphisms in these regions would be valuable. Haplotype association with breast cancer risk (n = 969; Global Haplotype Association p-value 0.0021)rs8179181rs8110090rs1800470rs1800469FrequencyOR (95% CI)P-value1GATC0.40281.002GACT0.23870.73 (0.55–0.97)0.033AATC0.17280.67 (0.48–0.93)0.0174GACC0.06710.49 (0.30–0.81)0.00545AACT0.0560.55 (0.30–1.00)0.0526GGTC0.02981.00 (0.48–2.09)0.997GGCT0.02271.82 (0.82–4.06)0.14 Citation Format: Mary A. Bewick, Michael SC Conlon. A population-based study of Transforming Growth Factor-Beta1 (TGFB1) polymorphisms and risk of breast cancer. [abstract]. In: Proceedings of the 104th Annual Meeting of the American Association for Cancer Research; 2013 Apr 6-10; Washington, DC. Philadelphia (PA): AACR; Cancer Res 2013;73(8 Suppl):Abstract nr 1336. doi:10.1158/1538-7445.AM2013-1336

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.001
metaresearch head score (Gemma)0.001
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.133
Threshold uncertainty score0.264

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0010.001
Meta-epidemiology (narrow)0.0010.000
Meta-epidemiology (broad)0.0000.001
Bibliometrics0.0010.002
Science and technology studies0.0010.000
Scholarly communication0.0010.000
Open science0.0010.000
Research integrity0.0010.001
Insufficient payload (model declined to judge)0.0040.001

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.031
GPT teacher head0.345
Teacher spread0.314 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2013
Admission routes2
Has abstractyes

Explore more

Same venueCancer ResearchSame topicTGF-β signaling in diseasesFrench-language works237,207